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Background: The carrier status of foot-and-mouth disease virus (FMDV) is complicated, and the role of carrier
animals in virus transmission is controversial. To investigate the carrier status of FMDV in animals that live in high
altitude, Bos grunniens yaks were infected experimentally with FMDV O/Akesu/58.
Results: All of the yaks showed clinical signs of foot-and-mouth disease (FMD). Total antibody levels against FMDV
measured by liquid-phase blocking enzyme-linked immunosorbent assay (LPB-ELISA) and antibody levels against
nonstructural proteins (NSP) showed dynamic changes. Three of the five yaks were indentified as carrier animals by
RT-PCR method, and the OP fluids from carrier yaks can cause cytopathic effect (CPE) on BHK-21 cells. At last, five
persistent infection strains were isolated. Nucleotide mutations of VP1 gene were analyzed.
Conclusions: After infected with FMDV, all of the yaks showed typical clinical signs. Yaks can keep carrier status for
at least 8 months. Total antibody levels against FMDV measured by LPB-ELISA and antibody levels against NSP were
at high level for carrier yaks. Sequence alignment of the five isolated strains showed obvious gene and protein
mutations.
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Foot-and-mouth disease (FMD) is one of the most con-
tagious viral diseases of cloven-hoofed livestock includ-
ing cattle, swine, sheep, and goat, as well as over 70
species of wild animals. The disease leads to high mor-
tality in young animals, high morbidity, and loss in prod-
uctivity [1-3]. Foot-and-mouth disease virus (FMDV),
the first demonstrated filterable agent causing animal
disease, is belong to the Aphtovirus genus of the
Picornaviridae family, and contains a single-stranded
positive-sense RNA genome of about 8500 nucleotides
[4]. As is the lack of error correction mechanism during
RNA replication, FMDV has a very high mutation rate
ranging from 10-3 to 10-5 per nucleotide site per genome
replication, which results in the presence of seven
serotypes, multiple subtypes, and variants [5,6].
Following acute phase of FMDV infection or vaccin-
ation, animals may experience persistent infection with-
out clinical signs, and these animals are defined as* Correspondence: changhuiyun@126.com
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reproduction in any medium, provided the orcarrier animals. The duration of the carrier status was
influenced by many factors including host species, and
breed [7]. Carrier animals are those from which live virus
can be recovered longer than 28 days after exposure [8].
Till now, virus isolation from esophageal-pharyngeal
(OP) fluids was thought to be the most sensitive method
to detect carrier animals [9,10]. Molecular techniques
for the diagnosis of persistent infection have been used
which offered a potential ability to improve the detec-
tion of a low genome copy number in clinical samples.
Several assays were described which utilized reverse
transcription-polymerase chain reaction (RT-PCR) for
the detection of FMDV [11,12]. With PCR and dotblot
hybridization, FMDV RNA was detected in probang
samples in which virus could be no longer isolated
[13-18]. African cattle was shown to excrete FMDV over
three years, sheep for up to one year, goats for up to
four months, and African buffalo for at least five years
[7,19,20]. No FMDV was detected in pigs from the OP
fluids which was sampled 28 days after infection, and
considered to be non-carriers of FMDV. However, a
study of the replication analysis of FMDV in swine
lymphoid tissue might indicate a putative carrier stage inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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living in a comparative friendly environment in low alti-
tude. The friendly environment was shown as: small
one day temperature difference, high oxygen concentra-
tion, and proper atmospheric pressure. Phenotype was
influenced by gene and environment, so animals in high
altitude regions showed different abilities to oxygen
concentration and temperature change. Other abilities
also showed different, such as the immune response
[22,23]. This may result in different evolution pressure
on pathogens invading animals.
To investigate whether animals in high altitude
regions experience a different carrier status and gene
mutation of FMDV, yaks, a special species living in
Qinghai-Tibet Plateau were infected experimentally
with the O/Akesu/58. OP fluids and blood were sam-
pled for detection of virus and antibodies level. Results
showed that yaks can carry FMDV for at least eight
months, and nucleotide, amino acid (AA) sequence of
VP1 shared some common mutations in isolated
strains [11]. What’s more, carrier yaks always had a
high antibody level.
Results
Clinical signs of yaks
All of the five yaks experienced acute phase, and showed
typical FMDV clinical signs. Fever and primary vesicles
were detected 18 h after inoculation. Twenty-four hours
after inoculation, body temperature was 41.2°C, and the
yaks showed more vesicles on the surface of tongue. Forty
hours after inoculation, some vesicles began to break up,
and vesicular lesions were detected on hoof crown. What’s
more, body temperature began to decline. One week after
inoculation, yaks came to recovery period.
Antibody levels during the carrier status and the
detection of virus
Total antibody levels against FMDV by LPB-ELISA were
shown in Figure 1. Total antibodies of the five yaksFigure 1 Total antibodies levels curve of the yaks. The antibody
level was measured by log2 titer of LBP-ELSA. MPI: month post-
infection.showed differences between individuals. All of the yaks
maintained a high antibody level for at least for
6 months. Total antibody level of yak C had declined
obviously since 7 month post-infection (MPI), while yak
B maintained a relatively high level until 8 MPI. 3ABC
antibody levels of the five yaks were measured by indir-
ect ELISA (Figure 2), and also showed individual differ-
ence. Two MPI, 3ABC antibody level reached the peak,
and then declined quickly. Yak B kept a high level, while
yak A and C showed relatively low antibody levels.
Presence of virus was identified by RT-PCR and CPE
(Table 1). The OP fluids were used for RT-PCR detec-
tion, and inoculated into BHK-21 cells to isolate the
virus strain. From Table 1, we can see that OP fluids
which were detected positive by RT-PCR can all lead to
CPE within ten times’ cell infection cycle, which indi-
cated the existence of live viruses. No live virus was
detected in yak A and C, while yak B kept the longest
carrier status. No virus was detected in samples from 10,
11, and 12 MPI. This indicated that carrier period of
yaks is at least 8 months.
Obviously, there was no certain correlation between
antibody level and the existence of virus. But total anti-
bodies and antibody against NSP were at high level for
carrier yaks. In this study, when the OD492 value of NSP
antibody level was above 1.2, and the titer of total anti-
bodies level was higher than 1:708, yak may experience
carrier status.
Nucleotide and AA mutation in VP1
The RT-PCR products of VP1 gene were sequenced.
Pairwise genetic distances of gene and protein sequence
distance were shown (Table 2; Table 3). Compared with
O/Akesu/58, the isolated strains showed 36 nucleotide
mutations. The five isolated strains shared 26 of 36 nu-
cleotide mutations. Fourteen AA mutations were foundFigure 2 The 3ABC antibody levels curve of the yaks. The 3ABC
antibody level was measured by the OD value of Indirect-ELISA. A-E
indicated the identity of the yaks. And the OD492 value of blanking
control was 0.2. MPI: month post-infection.
Table 1 The CPE and RT-PCR results of the OP fluids
MPI A B C D E
CPE RT-PCR CPE RT-PCR CPE RT-PCR CPE RT-PCR CPE RT-PCR
1 − − + + − − − − − −
2 − − + + − − − − + +
3 − − − − − − − − − −
4 − − − − − − − − − −
5 − − − − − − − − − −
6 − − − − − − + + − −
7 − − − − − − − − − −
8 − − + + − − − − − −
9 − − − − − − − − − −
10 − − − − − − − − − −
11 − − − − − − − − − −
12 − − − − − − − − − −
“+” the existence of CPE or the gene was detected by RT-PCR; “−” CPE was not observed or the gene was not detected by RT-PCR. MPI: month post-infection The
A-E indicated the identity of the yaks, and 1–12 means the MPI of sampling.
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strains shared 8 of 14 AA mutations.
Discussion
Similar with previous studies [24,25], yaks can experi-
ence acute phase and persistent infection after high-dose
FMDV was inoculated. Acute phase or vaccination could
cause persistent infection, so some people think that im-
mune status of animals may control virus replication
level [1,10,26-28]. Here, we find that yaks detected with
the existence of virus always had a high antibody level,
which indicated that the existence of high antibody level
can protect animals from clinical signs, but not enough
to clear virus completely. What’s more, virus was not
regularly detected during persistent infection. Obvious
gene and protein mutations of VP1 were observed, so
we postulated that the variation of VP1 may be a
possible reason for carrier status.
The role of carrier animals in virus transmission is
undetermined. The transmission from African buffalo to
cattle has obtained experimentally which indicated thatTable 2 The gene similarity of aligned sequences
Akesu/58 B01 B02 B08 D06 E02
Akesu/58 *** 95.1 95.1 95.3 95.3 95.8
B01 5 *** 99.1 99.2 99.2 99.4
B02 5 0.9 *** 99.5 99.5 99.4
B08 4.9 0.8 0.5 *** 99.7 99.5
D06 4.9 0.8 0.5 0.3 *** 99.5
E02 4.4 0.6 0.6 0.5 0.5 ***
The sequences were aligned by Clustal W Method in MegAlign. The upper
triangle shows the Percent Similarity of gene sequences of the five isolated
strains and O/Akesu/58, while the lower triangle shows the Percent
Divergence.carrier state can be a source of infection [29,30]. How-
ever, no experimental evidence showed that carrier cattle
or sheep can transmit virus to uninfected animals. The
persistent infection can lead to gene mutation [31], pos-
sibly being responsible for the generation of new viral
variants in the field. The research of persistent infection
and gene mutation of FMDV is a complicated and time-
consuming work. From this research, we can conclude
that yaks can keep carrier status for at least 8 months.
To further study the phenomenon, virulence of the iso-
lated strains to other species and reconstruct of these
mutation sits will be the aim of future work.
Conclusions
After infected with FMDV, all of the yaks showed typical
clinical signs. Yaks can keep carrier status for at least
8 months. Total antibody levels against FMDV measured
by LPB-ELISA and antibody levels against NSP were at
high level for carrier yaks. Sequence alignment of the
five isolated strains showed obvious gene and protein
mutations.
Materials and methods
Virus and virus inoculation
In this study, O/Akesu/58 (serotype O, isolated in
Akesu, XinJiang, 1958) which was adapted to suckling
mouse and BHK-21 was used. Per Yak was inoculated
under the mucosa of tongue with a dose of 104ID50
tested in cattle.
Yaks and treatment
Five 1-year-old yaks (Bos grunniens) were used in this
study. The yaks were free of antibodies against FMDV,
and the OP fluids of yaks were free of FMDV by RT-PCR.
Table 3 The protein similarity of aligned sequences
Akesu//58 B01 B02 B08 D06 E02
Akesu//58 *** 94.4 94.8 95.3 94.8 95.8
B01 5.9 *** 98.6 99.1 98.6 98.6
B02 5.4 1.4 *** 99.5 99.1 99.1
B08 4.9 0.9 0.5 *** 99.5 99.5
D06 5.4 1.4 0.9 0.5 *** 99.1
E02 4.4 1.4 0.9 0.5 0.9 ***
The sequences were aligned by Clustal W Method in MegAlign. The upper
triangle shows the Percent Similarity of protein sequences of the five isolated
strains and O/Akesu/58, while the lower triangle shows the Percent
Divergence.
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were all inoculated with O/Akesu/58. The yaks were
housed in Biological safety protection third-level (BSL-3)
animal homes of Lanzhou Veterinary Research Institute.
All tests were approved by the Animal Ethics Committee
of the Animal Sciences Group of Gansu Province.
Tissue samples and treatment
The yaks were sampled at 1 MPI, and kept being
sampled monthly for 12 months. Each sample was given
an identity number consisting of one letter and two
numbers. The letter means the identity of the yak, and
the two numbers represents the time of sampling. For
example, E03 means that the sample was collected from
yak E 3 MPI. Animals were kept being fasted for
12 hours before sampled. Five milliliter OP fluids and
10 ml blood were taken from each yak. The OP fluids
were moved into a centrifuge tube with equal volume of
PBS/TTE. Then the OP fluids were emulsified and
centrifuged at 3000 rpm. The supernatant was divided
into aliquot, and stored at −70°C. The blood samples
were treated with the procedure of 4°C 1 h, 37°C 1 min,
and then centrifuged at 4°C 5000 rpm for 10 min. The
serum was stored at –70°C.
Cells and cell infection
Baby hamster kidney (BHK-21) cells were cultured in
Dulbecco’s modified Eagle medium (DMEM; Invitrogen)
supplemented with 10% fetal bovine serum (FBS;
Hyclone). The well grown BHK-21 cells in 25 ml culture
plate were inoculated with 1 ml OP fluids. Four milliliter
sustaining medium was added per plate after 45 min ad-
sorption. Cells were maintained at 37°C in humidified
5% CO2 environment for no more than 72 h. Cell status
was observed every 3 h, and harvested when 95% CPE
appeared. The infected cells should be harvested within
72 h. Cells without CPE would go on next cell infection
cycle after three times of freeze-thaw [32]. Cell infection
cycles were done no more than 10 times for each sam-
ple. Samples were identified as negative when no CPE
was detected within 10 times of cell infection cycles.RNA extraction and RT-PCR detection
The treated OP fluids were used for RNA extraction
with RNeasy Mini Kit (QIAGEN). The existence of viral
RNA was measured by RT-PCR assay with the primers
for VP1. Primers were designed based on the genome
sequence of O/Akesu/58 with Oligo 7.0. The product
length is 639 bp. The primers were as following:
Forward primer 5'-TAGTGCGGTTAAAGCTTTG-3',
Reverse primer 5'-GACATGTCCTCCTGCATCTG-3'.
The reverse transcription was performed in the vol-
ume of 20 μl containing 2 μg of total RNA, 0.5 mM
dNTP each, 2.5 μM reverse primer, 4 μl 5 × AMV buffer,
and 0.5U/μl AMV reverse transcriptase (TaKaRa).
The PCR was performed in the volume of 50 μl. The
final concentration of each reagent was: 0.4 mM dNTP,
0.4 μM forward primer, 0.4 μM reverse primer, cDNA
6 μl, 10 × LA Buffer 5 μl, and LA Taq enzyme 0.05 U/μl
(TaKaRa).
T-A clone and sequencing of VP1
The RT-PCR products of VP1 were purified with Gel
DNA Extraction Kit (QIAGEN). T-A clone was performed
with pGEM-T Easy vector (Promega). The ligase product
was transformed into competent cells DH5α. The plas-
mids extracted with Plasmid Purification Kit (TaKaRa)
were identified with PCR. The positive plasmid was
sequenced by ABI-PRISM3730.
Antibody detection
The total FMDV antibodies were detected with a commer-
cial LPB-ELISA kit, and all procedures were performed
according to the manufacturer’s instructions [33].
To detect the antibody level against 3ABC NSP of
FMDV, a commercially available kit was used, and all
procedures were carried out by following the manufac-
turer’s instructions [34].
Sequence analysis
The nucleotide and protein sequences of the five isolate
strains (GenBank ID: JQ693472, JQ693473, JQ693474,
JQ693475, JQ693476) and O/Akesu/58 (GenBank ID:
AJ131469) were aligned by MegAlign in DNAstar, and
pairwise genetic distances were computed.
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